Longview Partners Portfolio holdings
Longview Partners is a specialist global equity manager that holds a concentrated portfolio of world stocks, using the same philosophy since it started in 2001. It looks for high-quality businesses that can build value steadily over time, wants a margin of safety on price, and relies on picking individual stocks rather than steering the overall portfolio. Its clients are institutions, and Northill Capital is its majority shareholder.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$668M |
| 2 |
Zimmer Biomet
ZBH
|
+$329M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity National Information Services
FIS
|
+$209M |
| 2 |
UnitedHealth
UNH
|
+$132M |
| 3 |
Accenture
ACN
|
+$106M |
| 4 |
Aptiv
APTV
|
+$92.8M |
| 5 |
Fiserv Inc
FISV
|
+$74.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.11% |
| 2 | Financials | 22.3% |
| 3 | Healthcare | 19.81% |
| 4 | Consumer Discretionary | 13.71% |
| 5 | Industrials | 10.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Aptiv
APTV
$7.86B
| $704M | 4.97% |
9,258,821
-1,207,733
| -12% | -$92.8M |
2013 Q2
9 quarters
|
|
2
Aon
AON
$70.7B
| $671M | 4.74% |
7,568,098
-235,642
| -3% | -$22.8M |
2013 Q2
9 quarters
|
|
3
Bank of New York Mellon
BNY
$103B
| $668M | 4.72% |
17,051,636
-668,909
| -4% | -$27.8M |
2013 Q2
9 quarters
|
|
|
4
Accenture
ACN
$148B
| $664M | 4.69% |
6,756,914
-1,070,099
| -14% | -$106M |
2013 Q2
9 quarters
|
|
5
Yum! Brands
YUM
$42.7B
| $661M | 4.67% |
11,495,057
-152,305
| -1% | -$9.22M |
2013 Q2
9 quarters
|
|
6
Wells Fargo
WFC
$257B
| $654M | 4.62% |
12,732,234
-393,595
| -3% | -$21.6M |
2013 Q2
9 quarters
|
|
|
7
Fiserv Inc
FISV
$32.7B
| $649M | 4.59% |
14,989,300
-1,727,348
| -10% | -$74.7M |
2013 Q2
9 quarters
|
|
|
8
Fidelity National Information Services
FIS
$14.6B
| $648M | 4.58% |
9,653,571
-3,135,592
| -25% | -$209M |
2013 Q2
9 quarters
|
|
9
Oracle
ORCL
$396B
| $637M | 4.5% |
17,639,350
-181,706
| -1% | -$6.99M |
2013 Q2
9 quarters
|
|
10
Progressive
PGR
$136B
| $637M | 4.5% |
20,793,258
-408,953
| -2% | -$12.4M |
2015 Q1
2 quarters
|
|
11
TE Connectivity
TEL
$62.4B
| $634M | 4.48% |
10,590,099
-141,960
| -1% | -$8.64M |
2013 Q2
9 quarters
|
|
|
12
UnitedHealth
UNH
$363B
| $630M | 4.45% |
5,426,300
-1,099,342
| -17% | -$132M |
2014 Q1
6 quarters
|
|
|
13
Thermo Fisher Scientific
TMO
$259B
| $627M | 4.43% |
+5,125,175
| New | +$668M |
2015 Q3
0 quarters
|
|
14
Pfizer
PFE
$164B
| $625M | 4.42% |
20,969,447
-434,689
| -2% | -$13.9M |
2013 Q2
9 quarters
|
|
15
HCA Healthcare
HCA
$105B
| $623M | 4.4% |
8,047,580
-831,916
| -9% | -$73.7M |
2013 Q3
8 quarters
|
|
16
Parker-Hannifin
PH
$121B
| $612M | 4.32% |
6,287,707
-21,042
| -0.3% | -$2.29M |
2015 Q2
1 quarter
|
|
|
TWX
17
DELISTED
Time Warner Inc
TWX
| $605M | 4.27% |
8,799,974
-120,707
| -1% | -$9.48M |
2013 Q2
9 quarters
|
|
18
Advance Auto Parts
AAP
$2.76B
| $576M | 4.07% |
3,037,355
-36,829
| -1% | -$6.38M |
2014 Q3
4 quarters
|
|
19
Truist Financial
TFC
$59.8B
| $527M | 3.72% |
14,803,345
-123,337
| -0.8% | -$4.76M |
2013 Q2
9 quarters
|
|
20
Emerson Electric
EMR
$91.6B
| $508M | 3.59% |
11,511,831
-96,497
| -0.8% | -$4.75M |
2015 Q1
2 quarters
|
|
|
VIAB
21
DELISTED
Viacom Inc. Class B
VIAB
| $363M | 2.57% |
8,414,424
-253,447
| -3% | -$12.6M |
2013 Q2
9 quarters
|
|
22
DELISTED
ADT Corp
ADT
| $307M | 2.17% |
10,264,811
-107,225
| -1% | -$3.48M |
2015 Q2
1 quarter
|
|
23
Omnicom Group
OMC
$23.7B
| $305M | 2.15% |
4,623,528
-55,880
| -1% | -$3.92M |
2014 Q1
6 quarters
|
|
|
24
Zimmer Biomet
ZBH
$19.8B
| $299M | 2.12% |
+3,283,844
| New | +$329M |
2015 Q3
0 quarters
|
|
25
Arrow Electronics
ARW
$10B
| $163M | 1.15% |
2,949,644
-47,207
| -2% | -$2.62M |
2013 Q2
9 quarters
|
|
Similar funds
Longview Partners's Q3 2015 Portfolio in Review
As of Q3 2015, Longview Partners held 26 positions worth $14.2B, down 7.1% from $15.2B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Longview Partners's Q3 2015 filing shows 2 new and 24 reduced positions. Its largest new stake was Thermo Fisher Scientific: 5,125,175 shares worth $627M. The largest sale was Fidelity National Information Services, an estimated $209M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.
- Longview Partners's largest Q3 2015 buy was Thermo Fisher Scientific: 5,125,175 shares worth $627M.
- Longview Partners's biggest Q3 2015 reduction was Fidelity National Information Services, cutting an estimated $209M.
- Longview Partners's ten largest holdings make up 47% of its $14.2B portfolio in Q3 2015.
- Longview Partners opened 2 new positions and closed 0 in Q3 2015.
- Longview Partners's portfolio value fell 7.1% quarter-over-quarter to $14.2B.
Based on Longview Partners's 13F filing for Q3 2015, filed 2 Nov 2015.